Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
8221
First IPO Date
March 04, 2003
| Name | Title | Pay | Year Born |
| Bao Hua Chen | GM, President & Director | 0 | 1962 |
| Bin He | Vice President | 0 | 1976 |
| Bo Xu | Vice President | 0 | 1973 |
| Qi Mao Chen | Vice President | 0 | 1958 |
| Lihong Lin | Vice President | 0 | 1977 |
| Mi Xu | Vice President | 0 | 1983 |
| Yanhua Meng | Vice President | 0 | 1979 |
| Sijia Guo | Executive Vice President & Director | 0 | 1963 |
| Yong Hua Zhu | Vice President, Secretary of the Board & Director | 0 | 1965 |
| Mei Zhang | Senior Vice President & Chief Financial Officer | 0 | 1976 |
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.